Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.

Brainstorm Cell Theraputc (BCLI)

Brainstorm Cell Theraputc (BCLI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
BrainStorm Cell Therapeutics Announces Full Year 2025 Financial Results and Provides Corporate Update PR Newswire - Tue Mar 31, 3:01PM CDT

Strategic $2.0 million post year-end financing and re-rating of BCLI shares underscore market confidence

BCLI : 0.9498 (+9.17%)
Brainstorm Cell Therapeutics Secures Second $1 Million Strategic Placement; Total $2 Million Raised In February PR Newswire - Thu Feb 26, 5:22AM CST

NEW YORK , Feb. 26, 2026 /PRNewswire/ -- Brainstorm Cell Therapeutics Inc. (OTCQB: BCLI), a leading developer of adult stem cell therapies for neurodegenerative diseases, today announced it has...

BCLI : 0.9498 (+9.17%)
Brainstorm Cell Therapeutics Announces $1 Million Strategic Financing at Premium to Market PR Newswire - Fri Feb 20, 5:00AM CST

NEW YORK , Feb. 20, 2026 /PRNewswire/ -- Brainstorm Cell Therapeutics Inc. (OTCQB: BCLI), a leading developer of adult stem cell therapies for neurodegenerative diseases, today announced it has...

BCLI : 0.9498 (+9.17%)
BrainStorm Cell Therapeutics Announces Third Quarter 2025 Financial Results and Provides Corporate Update PR Newswire - Fri Nov 14, 2025

NEW YORK , Nov. 14, 2025 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (OTCQB: BCLI), a leading developer of adult stem cell therapeutics for neurodegenerative diseases, today announced financial...

BCLI : 0.9498 (+9.17%)
Halper Sadeh LLC Encourages Brainstorm Cell Therapeutics Inc. Shareholders to Contact the Firm to Discuss Their Rights Business Wire - Mon Oct 27, 2025

Shareholders should contact the firm immediately as there may be limited time to enforce your rights.

BCLI : 0.9498 (+9.17%)
Halper Sadeh LLC Encourages Brainstorm Cell Therapeutics Inc. Shareholders to Contact the Firm to Discuss Their Rights Business Wire - Mon Oct 27, 2025

Shareholders should contact the firm immediately as there may be limited time to enforce your rights.

BCLI : 0.9498 (+9.17%)
Halper Sadeh LLC Encourages Brainstorm Cell Therapeutics Inc. Shareholders to Contact the Firm to Discuss Their Rights Business Wire - Mon Oct 27, 2025

Shareholders should contact the firm immediately as there may be limited time to enforce your rights.

BCLI : 0.9498 (+9.17%)
BrainStorm Cell Therapeutics Announces Second Quarter 2025 Financial Results and Provides Corporate Update PR Newswire - Thu Aug 14, 2025

Conference call and webcast scheduled for 8:30 a.m. Eastern Time Today, Thursday, August 14, 2025

BCLI : 0.9498 (+9.17%)
BrainStorm to Announce Second Quarter Financial Results and Provide a Corporate Update PR Newswire - Fri Aug 8, 2025

Call Scheduled for August 14, 2025 , at 8:30 AM Eastern Time

BCLI : 0.9498 (+9.17%)
BrainStorm Cell Therapeutics Announces Nasdaq Delisting and Transition to OTCQB PR Newswire - Thu Jul 17, 2025

NEW YORK , July 17, 2025 BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI) today announced that it has received a delisting notification from The Nasdaq Stock Market LLC, informing the...

BCLI : 0.9498 (+9.17%)

Barchart Exclusives

Ignore the Panic and Buy the Dip in Micron Stock, Says Bank of America Barchart - 1 hour ago
A sharp pullback in Micron stock tied to AI efficiency fears may be creating a compelling entry point as demand fundamentals remain intact. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.